| 标题 |
Safety and efficacy of mirikizumab versus secukinumab and placebo in the treatment of moderate-to-severe plaque psoriasis (OASIS-2): a phase 3, multicentre, randomised, double-blind study |
| 网址 | |
| DOI | |
| 其它 |
期刊:The Lancet Rheumatology 作者:Kim Papp; Richard B. Warren; Lawrence Green; Kristian Reich; Richard G. Langley; et al 出版日期:2023-08-21 |
| 求助人 | |
| 下载 | 该求助完结已超 24 小时,文件已从服务器自动删除,无法下载。 |
PDF的下载单位、IP信息已删除
(2025-6-4)